Cryptic SYT/SXX1 fusion gene in high-grade biphasic synovial sarcoma with unique complex rearrangement and extensive BCL2 overexpression

Cancer Genetics and Cytogenetics

Volumn 196, Issue 2, 2010, Pages 189-193

  Brassesco, María Sol ^a   Cortez, Maria Angélica ^a   Valera, Elvis Terci ^a   Engel, Edgard Eduard ^a   Nogueira Barbosa, Marcello Henrique ^a   Becker, Aline Paixão ^a   Scrideli, Carlos Alberto ^a   Tone, Luiz Gonzaga ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; HYBRID PROTEIN; IFOSFAMIDE; PROTEIN BCL 2; SYNOVIAL SARCOMA TRANSLOCATION SYNOVIAL SARCOMA X BREAKPOINT 1 FUSION PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CHROMOSOME 18; CHROMOSOME ANALYSIS; CHROMOSOME INSERTION; CHROMOSOME REARRANGEMENT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARYOTYPE; KARYOTYPE 47 XX; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHOULDER SURGERY; SPECTRAL KARYOTYPING; SYNOVIAL SARCOMA; TRISOMY 8; TUMOR BIOPSY; TUMOR VOLUME; X CHROMOSOME;

BASE SEQUENCE; DNA PRIMERS; FEMALE; GENE FUSION; GENE REARRANGEMENT; GENES, BCL-2; HUMANS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARCOMA, SYNOVIAL;

EID: 71949125096     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.10.001     Document Type: Article

References (24)

1. Fisher C., de Bruijn D.R.H., and Geurts van Kessel A. Synovial sarcoma. In: Fletcher C.D.M., Unni K.K., and Mertens F. (Eds). Pathology and Genetics of Tumours of Soft Tissue and Bone World Health Organization Classification of Tumours (2002), IARC Press, Lyon 200-205
2. Haldar M., Randall R.L., and Capecchi M.R. Synovial sarcoma: from genetics to genetic-based animal modeling. Clin Orthop Relat Res 466 (2008) 2156-2167
3. Turc-Carel C., Dal Cin P., Limon J., Li F., and Sandberg A.A. Translocation X;18 in synovial sarcoma. Cancer Genet Cytogenet 23 (1986) 93
4. Iliszko M., Rys J., Wozniak A., Chosia M., Sciot R., Debiec-Rychter M., and Limon J. Complex tumor-specific t(X;18) in seven synovial sarcoma tumors. Cancer Genet Cytogenet 189 (2009) 118-121
5. Brassesco M.S., Valera E.T., Neder L., Castro-Gamero A.M., Arruda D., Machado H.R., Sakamoto-Hojo E.T., and Tone L.G. Polyploidy in atypical grade II choroid plexus papilloma of the posterior fossa. Neuropathology 29 (2009) 293-298
6. In: Schaffer L.G., and Tommerup N. (Eds). ISCN: An International System for Human Cytogenetic Nomenclature (2005), S. Karger, Basel
7. Panagopoulos I., Mertens F., Isaksson M., Limon J., Gustafson P., Skytting B., Akerman M., Sciot R., Dal Cin P., Samson I., Iliszko M., Ryoe J., Debiec-Rychter M., Szadowska A., Brosjo O., Larsson O., Rydholm A., and Mandahl N. Clinical impact of molecular and cytogenetic findings in synovial sarcoma. Genes Chromosomes Cancer 31 (2001) 362-372
8. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
9. Sandberg A.A., and Bridge J.A. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Synovial sarcoma. Cancer Genet Cytogenet 133 (2002) 1-23
10. Szymanska J., Serra M., Skytting B., Larsson O., Virolainen M., Akerman M., Tarkkanen M., Huuhtanen R., Picci P., Bacchini P., Asko-Seljavaara S., Elomaa I., and Knuutila S. Genetic imbalances in 67 synovial sarcomas evaluated by comparative genomic hybridization. Genes Chromosomes Cancer 23 (1998) 213-219
11. Skytting B.T., Szymanska J., Aalto Y., Lushnikova T., Blomqvist C., Elomaa I., Larsson O., and Knuutila S. Clinical importance of genomic imbalances in synovial sarcoma evaluated by comparative genomic hybridization. Cancer Genet Cytogenet 115 (1999) 39-46
12. Lestou V.S., O'Connell J.X., Robichaud M., Salski C., Mathers J., Maguire J., Chudoba I., Sorensen P.H., Lam W., and Horsman D.E. Cryptic t(X;18), ins(6;18), and SYT-SSX2 gene fusion in a case of intraneural monophasic synovial sarcoma. Cancer Genet Cytogenet 138 (2002) 153-156
13. Torres L., Lisboa S., Cerveira N., Lopes J.M., Lopes C., and Teixeira M.R. Cryptic chromosome rearrangement resulting in SYT-SSX2 fusion gene in a monophasic synovial sarcoma. Cancer Genet Cytogenet 187 (2008) 45-49
14. Nagai M., Tanaka S., Tsuda M., Endo S., Kato H., Sonobe H., Minami A., Hiraga H., Nishihara H., Sawa H., and Nagashima K. Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2 alpha. Proc Natl Acad Sci USA 98 (2001) 3843-3848
15. Barco RB, Hunt LB, Frump AL, Garcia CB, Benesh A, Caldwell RL and Eid JE. The synovial sarcoma SYT-SSX2 oncogene remodels the cytoskeleton through activation of the Ephrin pathway. Mol Biol Cell 18:4003-4012.
16. Bruijn DRH, Nap JP, Geurts van Kessel A. The (Epi)genetics of human synovial sarcoma. Genes Chromosomes Cancer 46:107-117.
17. Fisher C. Soft-tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations. Virchows Arch (2009) Doi 10.1007/s00428-009-0776-0
18. Hirakawa N., Naka T., Yamamoto I., Fukuda T., and Tsuneyoshi M. Overexpression of bcl-2 protein in synovial sarcoma: a comparative study of other soft tissue spindle cell sarcomas and an additional analysis by fluorescence in situ hybridization. Hum Pathol 27 (1996) 1060-1065
19. Kawauchi S., Fukuda T., Oda Y., Saito T., Oga A., Takeshita M., Yokoyama K., Chuman H., Iwamoto Y., Sasaki K., and Tsuneyoshi M. Prognostic significance of apoptosis in synovial sarcoma: correlation with clinicopathologic parameters, cell proliferative activity, and expression of apoptosis-related proteins. Mod Pathol 13 (2000) 755-765
20. Pilotti S., Mezzelani A., Azzarelli A., Rilke F., and Pierotti M.A. bcl-2 expression in synovial sarcoma. J Pathol 184 (1998) 337-339
21. Lopes J.M., Nesland J.M., Reis-Filho J.S., and Holm R. Differential Ki67 and bcl-2 immunoexpression in solid-glandular and spindle cell components of biphasic synovial sarcoma: a double immunostaining assessment with cytokeratin and vimentin. Histopathology 40 (2002) 464-471
22. Hockenbery D., Nunez G., Milliman C., Schreiber R.D., and Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348 (1990) 334-336
23. Antonescu C.R., Kawai A., Leung D.H., Lonardo F., Woodruff J.M., Healey J.H., and Ladanyi M. Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma. Diagn Mol Pathol 9 (2000) 1-8
24. Mancuso T., Mezzelani A., Riva C., Fabbri A., Dal Bo L., Sampietro G., Perego P., Casali P., Zunino F., Sozzi G., Pierotti MA., and Pilotti S. Analysis of SYT-SSX fusion transcripts and bcl-2 expression and phosphorylation status in synovial sarcoma. Lab Invest 80 (2000) 805-813